News

Deal Announcements

BeneChill Garners New Venture Capital Equity

Friday, February 22, 2013 5:56:00 AM PDT | VentureDeal
   San Diego, California  --  Medical technology firm BeneChill has secured nearly $6.6 million in new venture capital equity investment, according to an SEC regulatory filing.

BeneChill is developing technology that reduces tissue damage in patients with cerebral ischemia.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

BeneChill is still seeking $2.9 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1